Your session is about to expire
← Back to Search
Remote Ischemic Conditioning
Remote Ischemic Conditioning for Bone Marrow Transplant Patients (RICH Trial)
N/A
Waitlist Available
Led By Thomas Ryan
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Pediatric, adolescent, or young adult patients, 10 years of age or above
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18-24 months from start of enrollment
Awards & highlights
RICH Trial Summary
This trial will test a new way to reduce heart damage in children undergoing cancer treatment. If successful, it could lead to fewer heart problems for these kids down the road.
Who is the study for?
This trial is for pediatric and young adult patients, aged 10 or above, who can handle having their upper arm blood pressure taken. They must be part of the BMT Biorepository study and have a systolic blood pressure under 160 mmHg. Those with clotting disorders, chronic kidney disease, certain heart conditions, or low platelet counts cannot join.Check my eligibility
What is being tested?
The study is testing the safety and tolerability of remote ischemic conditioning (autoRIC®) in young patients receiving bone marrow transplants at Cincinnati Children's Hospital. It aims to see if this procedure reduces heart damage by monitoring through blood tests and echocardiograms.See study design
What are the potential side effects?
While specific side effects are not listed for autoRIC®, it generally involves inflating a cuff on the arm which could cause discomfort or bruising. The risk of more serious side effects will be assessed during this safety-focused trial.
RICH Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRICH Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18-24 months from start of enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18-24 months from start of enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adverse events
RICH Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Therapeutic GroupExperimental Treatment1 Intervention
Therapeutic group receives remote ischemic conditioning.
Group II: Control GroupActive Control1 Intervention
Control group does not receive remote ischemic conditioning.
Find a Location
Who is running the clinical trial?
Children's Hospital Medical Center, CincinnatiLead Sponsor
815 Previous Clinical Trials
6,531,556 Total Patients Enrolled
Thomas RyanPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati
1 Previous Clinical Trials
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a known condition affecting your blood vessels, such as peripheral vascular disease or vasculitis.You have been diagnosed with certain heart conditions like cardiomyopathy or congenital heart disease, except for a specific type called bicuspid aortic valve.
Research Study Groups:
This trial has the following groups:- Group 1: Therapeutic Group
- Group 2: Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many volunteers have enrolled in this experiment?
"Affirmative. Data hosted on clinicaltrials.gov attests to this medical trial's recruitment status, with the initial post-date being August 21st 2018 and the most recent update occurring on September 9th 2022. 40 individuals are needed from 1 site for this research endeavour."
Answered by AI
Are there still opportunities for participants to join this trial?
"Affirmative. The information found on clinicaltrials.gov confirms that this experiment is still seeking volunteers, with the initial post on August 21st 2018 and most recent amendment made September 9th 2022. This research requires 40 enrollees at a single site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger